S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6992 −0.02%
PRE-MKT · 05:55 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead

VNOV

VitaNova Life Sciences Corp
OTC · INDUSTRIALS · WHOLESALE-APPAREL, PIECE GOODS & NOTIONS
2.82
+0.00 +0.00%
USD · close Nov 18

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $23.5MP/E —DIV YIELD —FCF YIELD —REV TTM $3.2M +22.0%NET INCOME −$114K −113.3%NET CASH —52W 1.38 – 4.83SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 47 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q1 2027 · Jul 31$322K+209.5%9.5%−$122K−$123K—-0.01$7K——Sep 14
Q4 2026 · Apr 30derived$1.8M−8.6%14.8%−$110K$18K−97.8%0.01$428K——Jul 29
Q3 2026 · Jan 31$710K+130.2%44.6%$47K−$44K−160.8%-0.01−$90K——Mar 16
Q2 2026 · Oct 31$427K+46.2%61.1%$99K$36K+9.7%0.00$213K——Mar 16
Q1 2026 · Jul 31$104K−4.2%66.2%−$32K−$46K—0.00$264K——Sep 14
Q4 2025 · Apr 30derived$2M+258.7%59.3%$1.1M$800K+376.6%0.02$479K——Jul 29
Q3 2025 · Jan 31$308K+1081.3%61.4%$109K$73K+1126.9%0.01$209K——Mar 16
Q2 2025 · Oct 31$292K—53.3%$63K$33K—0.00$9K——Mar 16
Q1 2025 · Jul 31$108K—67.5%−$45K−$55K—0.00−$504K——Mar 16
Q4 2024 · Apr 30derived$545K—64.6%$233K$168K—0.01−$191K——Jul 24
Q3 2024 · Jan 31$26K—100.0%$6K$6K—0.00−$151K——Mar 17
Q2 2024 · Oct 31$0——−$9K−$9K—0.00−$8K——Mar 17

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2026 · to Apr 30$3M30.1%$4K−$37K-1.2%-0.00$814K————
FY2025 · to Apr 30$2.7M59.2%$1.2M$851K32.0%0.03$193K————
FY2024 · to Apr 30$571K66.2%$206K$141K24.7%0.01−$376K————
FY2023 · to Apr 30$38K100.0%−$24K−$24K-63.8%0.00−$18K————
FY2022 · to Apr 30$120K—−$13K$140K116.4%0.02$4K————
FY2021 · to Apr 30$0—−$52K−$52K—-0.01−$42K————

Every number comes from VitaNova Life Sciences Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch VNOV. Know when insiders buy.
One email the day a filing lands. Free.